However, more studies are needed to assess the relevance of in vivo targeting of specific neuronal subtypes, including dopaminergic, glutamatergic, and GABAergic neurons, highlighting the need to develop this approach for receptors that exhibit dynamic expression in NDs
However, both can cause water retention, carpal tunnel symptoms, and effects on glucose metabolism at higher doses
A 2006 review of the field by an active research group described DSIP as a still unresolved riddle a description that, twenty years later, the published literature has not displaced (Kovalzon & Strekalova, 2006)
Disclaimer: Injectable peptides like GLOW are not FDA-approved
A clear red flag: any provider offering post-surgical IV therapy without reviewing your medical history, surgical details, and recent blood results is not meeting the standard of care this treatment requires
MAbs 14 , 2014296 (2022)